Similar articles for PMID: 32518122

Year	Number of Results
1999	1
2003	1
2004	2
2005	3
2006	1
2007	5
2008	5
2009	2
2010	1
2011	6
2012	5
2013	13
2014	11
2015	11
2016	11
2017	14
2018	13
2019	20
2020	27
2021	40
2022	39
2023	9
2024	0

1

Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential ¹⁸F-FDG PET Examinations.

Ostwani W, Hanna C, Brice AE, Wymer DC. Ostwani W, et al. J Nucl Med Technol. 2020 Dec;48(4):378-380. doi: 10.2967/jnmt.120.246322. Epub 2020 Jun 9. J Nucl Med Technol. 2020. PMID: 32518122 Free article. Review.

2

Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.

Christopoulos G, Jouni H, Acharya GA, Blauwet LA, Kapa S, Bois J, Chareonthaitawee P, Rodriguez-Porcel MG. Christopoulos G, et al. J Nucl Cardiol. 2021 Apr;28(2):661-671. doi: 10.1007/s12350-019-01746-4. Epub 2019 May 20. J Nucl Cardiol. 2021. PMID: 31111450

3

Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.

Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS. Wisenberg G, et al. J Nucl Cardiol. 2020 Dec;27(6):2118-2129. doi: 10.1007/s12350-018-01578-8. Epub 2019 Jan 2. J Nucl Cardiol. 2020. PMID: 30603887 Free PMC article.

4

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF. Blankstein R, et al. J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16. J Am Coll Cardiol. 2014. PMID: 24140661 Free PMC article.

5

The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.

Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, Birnie D, Beanlands RS, Nery PB. Mc Ardle BA, et al. J Nucl Cardiol. 2013 Apr;20(2):297-306. doi: 10.1007/s12350-012-9668-9. Epub 2013 Jan 4. J Nucl Cardiol. 2013. PMID: 23288545 Review.

6

Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on ¹⁸F-FDG PET Scans for Suspected Cardiac Sarcoidosis.

Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, Cerqueira MD, Hachamovitch R. Sperry BW, et al. JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):336-345. doi: 10.1016/j.jcmg.2017.04.020. Epub 2017 Aug 16. JACC Cardiovasc Imaging. 2018. PMID: 28823747 Free article.

7

Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.

Maeda D, Kanzaki Y, Fujita S, Inuyama M, Takashima S, Miyamura M, Terasaki F, Hoshiga M. Maeda D, et al. ESC Heart Fail. 2019 Aug;6(4):889-893. doi: 10.1002/ehf2.12472. Epub 2019 Jul 2. ESC Heart Fail. 2019. PMID: 31264810 Free PMC article.

8

Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.

Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR. Kebed KY, et al. Int J Cardiovasc Imaging. 2021 Apr;37(4):1361-1369. doi: 10.1007/s10554-020-02090-2. Epub 2020 Nov 22. Int J Cardiovasc Imaging. 2021. PMID: 33225427 Free PMC article.

9

Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.

Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB. Ohira H, et al. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):259-269. doi: 10.1007/s00259-015-3181-8. Epub 2015 Sep 11. Eur J Nucl Med Mol Imaging. 2016. PMID: 26359191

10

Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/¹⁸F-fluorodeoxyglucose positron emission tomography examinations.

Tanaka TD, Nagai T, Nagoshi T, Yoshimura M. Tanaka TD, et al. J Nucl Cardiol. 2020 Dec;27(6):2149-2153. doi: 10.1007/s12350-019-01968-6. Epub 2019 Nov 26. J Nucl Cardiol. 2020. PMID: 31773564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year